Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Dronedarone
100%
Provider-level
100%
Patient-level
100%
Fenofibrate
75%
Permanent Atrial Fibrillation
75%
Medicare
50%
Medication Use
50%
Statins
50%
Type 2 Diabetic Patients
50%
New Evidence
50%
New Therapies
25%
Medicaid
25%
Lipids
25%
Medicare Fee-for-service
25%
Patient Characteristics
25%
Diabetes Patients
25%
Timely Access
25%
Level Characteristic Values
25%
Pallas
25%
Quality Healthcare
25%
Provider Characteristics
25%
Interrupted Time Series Regression
25%
Cardiologists
25%
Primary Care Providers
25%
Atrial Fibrillation Patient
25%
Time Series Regression Model
25%
Nursing and Health Professions
Dronedarone
100%
Medicare
75%
Permanent Atrial Fibrillation
75%
Fenofibrate
75%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Patient with Type 2 Diabetes
50%
Primary Medical Care
25%
Medicaid
25%
Cardiologist
25%
Lipid
25%
Time Series Analysis
25%
Primary Health Care
25%
Quality Health Care
25%
Medicine and Dentistry
Dronedarone
100%
Medicare
75%
Fenofibrate
75%
Permanent Atrial Fibrillation
75%
Statin
50%
Patient with Type 2 Diabetes
50%
Medicaid
25%
Diabetes
25%
Primary Health Care
25%
Lipid
25%
Quality of Health Care
25%
Time Series Analysis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Dronedarone
100%
Fenofibrate
75%
Permanent Atrial Fibrillation
75%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
50%
Maturity Onset Diabetes of the Young
50%
Lipid
25%